{
    "componentChunkName": "component---src-templates-country-js",
    "path": "/fr/country/uzb",
    "result": {"data":{"locales":{"edges":[{"node":{"ns":"translations","data":"{\"ia2030 scorecard\":\"Tableau de bord IA2030\",\"return home\":\"Retour à la page d’accueil\",\"select a region\":\"Sélectionnez une région\",\"overview\":\"Aperçu\",\"impact goals\":\"Objectif en termes d'impact\",\"strategic priorities\":\"Objectifs prioritaires stratégiques\",\"country pages\":\"Pages Pays\",\"share this page\":\"Partager cette page\",\"main menu\":\"Menu principal\",\"Save Lives\":\"Sauver des vies\",\"Control, eliminate & eradicate VPDs\":\"Combattre, éliminer e éradiquer les MEV\",\"Reduce VPD outbreaks\":\"Réduire les flamblées de MEV\",\"Leave no child behind\":\"Ne laisser personne de côté\",\"Provide access to all vaccines\":\"Donner accès à tous les vaccins\",\"Deliver across the life course\":\"Vacciner tout au long de la vie\",\"Strengthen universal health coverage\":\"Renforcer la couverture sanitaire universelle\",\"Leadership, management, coordination\":\"Leadership, gestion, coordination\",\"Health workforce\":\"Personnel de santé\",\"Surveillance\":\"Surveillance\",\"Supply chain\":\"Chaîne d'approvisionnement\",\"Vaccine safety\":\"Sécurité des vaccins\",\"Political and financial commitment\":\"Engagement politique et financier\",\"Demand for immunization\":\"Demande de vaccination\",\"High & equitable coverage\":\"Couverture élevée et équitable\",\"Life-course vaccination\":\"Vaccination au cours de la vie\",\"Outbreak detection and response\":\"Détection et réponse aux épidémies\",\"Healthy global markets for vaccines\":\"Marchés mondiaux des vaccins sains\",\"Financial resources for imm. programmes\":\"Ressources financières des programmes de vaccination\",\"Imm. expenditure from domestic resources\":\"Financement des vaccins par les ressources nationales\",\"Capacity for innovation\":\"Capacité d'innovation\",\"New vaccine development\":\"Développement d'un nouveau vaccin\",\"type to select a country\":\"Type pour sélectionner un pays\",\"Immunization Agenda 2030 Scorecard\":\"Tableau de bord de Programme pour la vaccination à l’horizon 2030\",\"overview dashboard\":\"Tableau de bord général\",\"Impact Goal Indicators\":\"Indicateurs relatifs aux objectif d’impact\",\"global\":\"Global\",\"Strategic Priority Indicators\":\"Indicateurs relatifs aux objectifs stratégiques prioritaires\",\"how to read the charts\":\"comment lire les graphiques\",\"baseline or year first reported\":\"Base de référence ou année de la première déclaration\",\"2030 target\":\"Objectif 2030\",\"on track toward 2030 target\":\"En voie d’accomplissement de l'objectif 2030\",\"off track toward 2030 target\":\"L'objectif de 2030 n'est pas sur la bonne voie\",\"stable or no change\":\"Stable ou pas de changement\",\"explore data\":\"explorer les données\",\"cumulative number of deaths averted\":\"Nombre cumulé de décès évités\",\"pace needed as of 2022 to be on track toward 2030 target\":\"Le rythme doit être maintenu à partir de 2022 pour atteindre l'objectif de 2030\",\"to be on track for 2030 target, cumulative future deaths averted globally should reach here\":\"Pour atteindre l'objectif de 2030, le nombre cumulé de décès futurs évités au niveau mondial devrait atteindre ce chiffre\",\"Cholera\":\"Choléra\",\"Ebola\":\"Ebola\",\"Measles\":\"Rougeole\",\"Meningococcus\":\"Meningococcus\",\"Poliovirus (cVDPV)\":\"Poliovirus circulant dérivés d’une souche vaccinale (PVDVc)\",\"Poliovirus (WPV)\":\"Poliovirus sauvage (PVS)\",\"Yellow Fever\":\"Fièvre jaune\",\"Japanese Enc. Virus\":\"Virus de l'encéphalite japonaise\",\"Rubella\":\"Rubéole\",\"Human Papilloma Virus\":\"Virus du papillome humain\",\"Tetanus\":\"Tétanos\",\"Hepatitis B\":\"Hépatite B\",\"Maternal & Neonatal Tetanus\":\"Tétanos maternel et néonatal\",\"countries that have achieved target\":\"Pays ayant atteint l'objectif\",\"countries that have not achieved target\":\"Pays n'ayant pas atteint l'objectif\",\"countries with no endorsed target\":\"Pays n'ayant pas d'objectif approuvé\",\"number of large or disruptive outbreaks at baseline\":\"Nombre de foyers importants ou perturbateurs au moment de l'enquête de référence\",\"current progress on zero dose children\":\"Progrès actuels concernant les enfants à zéro dose\",\"baseline measure of 13M as of 2019\":\"Mesure de référence de 13 millions à partir de 2019\",\"cumulative vaccine introductions\":\"Introductions cumulées de vaccins\",\"to be on track for 2030 target, the number of cumulative vaccine introductions should reach here\":\"Pour atteindre l'objectif de 2030, le nombre d'introductions cumulées de vaccins devrait atteindre ce chiffre\",\"PCV3\":\"VPC3\",\"HPVc\":\"PVHc\",\"vaccination coverage in baseline year\":\"Couverture vaccinale au cours de l'année de référence\",\"uhc index in most recent year\":\"Indice CHU dans l'année la plus récente\",\"baseline UHC Service Coverage Index at\":\"Indice de base de la couverture des services de la CSU à\",\"positive change since last update\":\"Changement positif depuis la dernière mise à jour\",\"negative change since last update\":\"Changement négatif depuis la dernière mise à jour\",\"no change\":\"Pas de changement\",\"data not yet available\":\"Données non encore disponibles\",\"insufficient data at the regional level\":\"Données insuffisantes au niveau régional\",\"click to explore data for this indicator\":\"cliquez pour explorer les données de cet indicateur\",\"mean across antigens\":\"Moyenne entre les antigènes\",\"DTPCV3\":\"DTC3\",\"MCV1\":\"MCV1\",\"horizontal bar chart showing progress of\":\"Diagramme à barres horizontales montrant la progression de\",\"towards goal of 50 million.\":\"vers l'objectif de 50 millions.\",\"horizontal bar chart showing that\":\"Diagramme à barres horizontales montrant que\",\"countries have achieved their target out of\":\"pays ont atteint leur objectif sur\",\"who have endorsed a target in\":\"qui ont approuvé un objectif en\",\"horizontal bar chart showing\":\"Diagramme à barres horizontales montrant\",\"outbreaks in\":\"d'épidémies en\",\"toward goal of 50% reduction in zero dose children.\":\"vers l'objectif de réduction de 50 % des enfants à zéro dose\",\"vaccine introductions out of goal of 500.\":\"d'introductions de vaccins sur un objectif de 500.\",\"horizontal bar chart showing progress\":\"Diagramme à barres horizontales montrant la progression\",\"toward goal of 90% coverage.\":\"vers l'objectif d'une couverture de 90 %.\",\"horizontal bar chart showing value of\":\"Diagramme à barres horizontales montrant la valeur de\",\"horizontal bar chart showing the\":\"Diagramme à barres horizontales indiquant le\",\"physicians, nurses and midwives per 10,000 population.\":\"de médecins, d'infirmières et de sages-femmes pour 10 000 habitants\",\"of countries have at least 1 documented individual serious AEFI case safety report per million total population.\":\"de pays disposant d'au moins un rapport de sécurité documenté (avec formulaire de déclaration et/ou ligne indiquée) sur un cas individuel de MAPI grave, par million d'habitants\",\"of countries that have legislation in place that is supportive of immunization as a public good.\":\"de pays ayant mis en place une législation favorable à la vaccination en tant que bien public\",\"of countries that have implemented behavioural or social strategies to address under-vaccination.\":\"de pays ayant mis en œuvre des stratégies comportementales ou sociales pour lutter contre la sous-vaccination\",\"horizontal bar chart showing coverage\":\"Diagramme à barres horizontales montrant la couverture\",\"in the 20% of districts with lowest coverage of\":\"dans les 20 % de districts ayant la plus faible couverture de\",\"of outbreaks with timely detection and response.\":\"de foyers épidémique ayant fait l'objet d'une détection et d'une intervention en temps utile\",\"of countries whose domestic government and donor expenditure on primary health care increased or remained stable.\":\"de pays dont les dépenses des gouvernements nationaux et des donateurs pour les soins de santé primaires ont augmenté ou sont restées stables\",\"of countries whose share of national immunization schedule vaccine expenditure funded by domestic government resources increased or remained stable.\":\"de pays dont la part des dépenses liées aux vaccins du calendrier national de vaccination financée par des ressources publiques nationales a augmenté ou est restée stable\",\"of countries with an immunization research agenda.\":\"de pays ayant un programme de recherche sur la vaccination\",\"download chart\":\"Télécharger le tableau\",\"Baseline\":\"Donnée de référence\",\"Baseline (rounded)\":\"ligne de base (valeurs arrondies)\",\"summary table\":\"Tableau récapitulatif\",\"income group data not yet available for this indicator.\":\"Les données relatives au groupe de revenu ne sont pas encore disponibles pour cet indicateur\",\"insufficient data at the regional level.\":\"Données insuffisantes au niveau régional\",\"switch back to the Global view for data on this indicator.\":\"Revenez à la vue globale pour obtenir des données sur cet indicateur\",\"global target\":\"Objectif Global\",\"deaths averted due to\":\"décès évités grâce à la\",\"immunization against\":\"vaccination contre\",\"Base\":\"Donnée de\",\"line\":\"référence\",\"BL\":\"DR\",\"Stacked bar chart of number of future deaths averted through immunization each year divided up by vaccine with the goal of reaching 5.8 million deaths averted globally.\":\"Diagramme à barres empilées du nombre de décès futurs évités grâce à la vaccination chaque année, divisé par vaccin, l'objectif étant d'atteindre 5,8 millions de décès évités dans le monde\",\"Hib\":\"Hib\",\"HPV\":\"PVH\",\"JE\":\"EJ\",\"MenA\":\"MENA\",\"Streptococcus pneumoniae\":\"Streptococcus pneumoniae\",\"Rotavirus\":\"Rotavirus\",\"Yellow fever\":\"Fièvre Jaune\",\"Diphtheria\":\"Diphtérie\",\"Pertussis\":\"Coqueluche\",\"TB (BCG)\":\"TB (BCG)\",\"Total\":\"Total\",\"Mean\":\"Moyenne\",\"DTP3\":\"DTC3\",\"IPV\":\"VPI\",\"MCV2\":\"MCV2\",\"Pneumonia\":\"Pneumonia\",\"WPV\":\"Poliovirus sauvage (PVS)\",\"pathogen\":\"Pathogène\",\"not measured\":\"Non mesuré\",\"A table that lists diseases and the number of deaths averted each year.\":\"Un tableau qui répertorie les maladies et le nombre de décès évités chaque année.\",\"how to read this chart\":\"Comment lire ce tableau\",\"countries with\":\"Pays avec\",\"no endorsed target\":\"pas de cible avalisée\",\"countries that have\":\"Les pays qui ont\",\"not achieved\":\"non atteint\",\"target\":\"cible\",\"disease is\":\"La maladie est\",\"re-established\":\"rétabli\",\"in this country\":\"dans ce pays\",\"newly achieved\":\"nouvellement atteint\",\"target in this year\":\"objectif de cette année\",\"achieved\":\"atteint\",\"Japanese Encephalitis Virus — Control Target\":\"Virus de l'encéphalite japonaise - Objectif de contrôle\",\"Measles — Elimination of Transmission Target\":\"Rougeole - Objectif d'élimination de la transmission\",\"Rubella — Elimination of Transmission Target\":\"Rubéole - Objectif d'élimination de la transmission\",\"Hepatitis B Virus — Elimination of Epidemic Target\":\"Virus de l'hépatite B - Objectif d'élimination de l'épidémie\",\"Tetanus — Elimination of Epidemic Target\":\"Tétanos - Objectif d'élimination de l'épidémie\",\"Wildtype Poliovirus — Eradication Target\":\"Poliovirus de type sauvage - Objectif d'éradication\",\"Maternal & Neonatal Tetanus — Elimination as a Public Health Problem\":\"Tétanos maternel et néonatal - Élimination en tant que problème de santé publique\",\"endorsing\":\"cible de\",\"Target\":\"soutien\",\"countries\":\"Pays\",\"Stacked bar chart showing number countries who have achieved their target out of those who have endorsed a target for\":\"Diagramme à barres empilées montrant le nombre de pays qui ont atteint leur objectif parmi ceux qui ont approuvé un objectif pour\",\"target type\":\"Type de cible\",\"disease\":\"Maladie\",\"no. of countries achieving target out of those with target\":\"Nombre de pays ayant atteint leur objectif parmi ceux qui en ont un\",\"Control\":\"Contrôle\",\"Elimination of Transmission\":\"Elimination de la transmission\",\"Elimination of Epidemic\":\"Elimination de l'épidémie\",\"Eradication\":\"Eradication\",\"Elimination as a Public Health Problem\":\"L'élimination en tant que problème de santé publique\",\"out of\":\"sur\",\"A table that lists diseases categorized by target type and the number of countries achieving the target each year\":\"Un tableau qui répertorie les maladies classées par type d'objectif et le nombre de pays atteignant l'objectif chaque année\",\"number of large or disruptive outbreaks\":\"Nombre d'épidémies importantes ou perturbatrices\",\"stable\":\"stable\",\"increasing\":\"croissant\",\"decreasing\":\"décroissant\",\"Bar chart of number of large or disruptive VPD outbreaks by year of\":\"Diagramme à barres du Nombre d’épidémies importantes ou perturbatrices de MEV par année de\",\"A table that lists diseases and the numbers of outbreaks in each year\":\"Un tableau qui répertorie les maladies et le nombre d'épidémies pour chaque année\",\"annual avg.\":\"Moyenne Annuelle\",\"TargetALT\":\"Objectif\",\"Bar chart showing the trend of number of zero dose children by year with the goal of 50% reduction\":\"Diagramme à barres montrant la tendance du nombre d'enfants à dose zéro par année avec l'objectif d'une réduction de 50 %\",\"number of zero dose children\":\"Nombre d'enfants à zéro dose\",\"A table that shows the number of zero dose children each year.\":\"Un tableau qui montre le nombre d'enfants à dose zéro chaque année\",\"average of 50 annual introductions\":\"Moyenne de 50 introductions annuelles\",\"introductions\":\"introductions\",\"Bar chart showing number of new or under-utilized vaccines in low and middle income countries by year.\":\"Diagramme à barres montrant le nombre de vaccins nouveaux ou sous-utilisés dans les pays à revenu faible ou intermédiaire, par année\",\"vaccine introductions\":\"Introduction des vaccins\",\"Covid\":\"Covid\",\"DTP Booster\":\"Rappel DTC\",\"HepB BD\":\"HepB dose de naissance\",\"HiB\":\"HiB\",\"IPV2\":\"VPI2\",\"PCV\":\"VPC\",\"Hep A\":\"Hep A\",\"Influenza\":\"Grippe\",\"Multivariant Men\":\"Méningite multivariée\",\"Mumps\":\"Oreillons\",\"Rabies\":\"Rage\",\"Typhoid\":\"Typhoïde\",\"Varicella\":\"Varicelle\",\"DTP Booster 1\":\"Rappel du DTC dose 1\",\"DTP Booster 2\":\"Rappel du DTC dose 2\",\"DTP Booster 3\":\"Rappel du DTC dose 3\",\"Malaria\":\"Paludisme\",\"A table that shows the number of vaccine introductions each year.\":\"Un tableau qui montre le nombre d'introductions de vaccins chaque année\",\"First Year\":\"Première année\",\"Second Year\":\"Deuxième année\",\"Adolescents\":\"Adolescents\",\"vaccine\":\"Vaccin\",\"Bar chart showing percentage of vaccine coverage by year for\":\"Diagramme à barres montrant le pourcentage de couverture vaccinale par année pour\",\"A table that lists vaccines and the percentage of coverage each year.\":\"Un tableau qui répertorie les vaccins et le pourcentage de couverture chaque année\",\"increase\":\"Augmentation par rapport \",\"from baseline\":\"à la base de référence\",\"Bar chart showing UHC index of service coverage by year.\":\"Diagramme à barres montrant l'indice de couverture des services du CHU par année\",\"uhc index\":\"Indice de couverture sanitaire universelle\",\"A table that shows UHC Index for each year.\":\"Un tableau qui montre l'indice de couverture sanitaire universelle pour chaque année\",\"year\":\"Année\",\"map-disclaimer\":\"La présentation des cartes ne constitue pas l'expression de l'opinion du Programme de vaccination 2030 concernant le statut juridique des pays/territoires, de leurs autorités dirigeantes ou de leurs frontières officielles\",\"Map showing density of physicians, nurses and midwives.\":\"Carte montrant la densité des médecins, des infirmières et des sages-femmes.\",\"density of physicians, nurses/midwives\":\"Densité des médecins, des infirmières / sages-femmes\",\"A table that shows the density of physicians, nurses and midwives.\":\"Tableau montrant la densité des médecins, des infirmières et des sages-femmes.\",\"vigiBase data\":\"Données VigiBase\",\"Bar chart showing proportion of countries with at least 1 documented individual serious AEFI case safety report per million total population\":\"Diagramme à barres montrant la proportion de pays ayant fait l'objet d'un rapport sur la sécurité d'au moins un cas individuel grave de MAPI documenté, par million d'habitants\",\"proportion of countries\":\"Proportion de pays\",\"A table that shows proportion of countries with at least 1 documented individual serious AEFI case safety report per million total population for each year.\":\"Un tableau qui montre la proportion de pays ayant au moins un rapport de sécurité documenté sur un cas individuel grave de MAPI par million de population totale pour chaque année.\",\"countries reported no data, not relevant, or did not report, excluded from analysis\":\"Pays ayant rapporté que les données sont indiponibles donnée, ou non pertinentes, ou n'ayant pas fourni de données, sont exclus de l'analyse\",\"No data/Not relevant/No response\":\"Pas de données/Pas de pertinence/Pas de réponse\",\"Stacked bar chart of proportion of countries with legislation in place that is supportive of immunization as a public good.\":\"Diagramme à barres empilées de la proportion de pays disposant d'une législation favorable à l'immunisation en tant que bien public\",\"number of countries\":\"Nombre de pays\",\"total with response\":\"Total avec réponse\",\"With vaccination or other legislation that is supportive as a public good\":\"Avec la vaccination ou d'autres lois qui soutiennent comme un bien public\",\"Without vaccination or other legislation that is supportive as a public good\":\"Sans la vaccination ou une autre législation qui soutiennent comme un bien public\",\"No data\":\"Pas de données\",\"No response\":\"Pas de réponse\",\"Not relevant\":\"Non pertinent\",\"A table that lists the proportion of countries with legislation in place that is supportive of immunization as a public good.\":\"Un tableau qui répertorie la proportion de pays ayant une législation en place qui soutient la vaccination comme un bien public\",\"Stacked bar chart of proportion of countries that have implemented behavioral or social strategies to address under-vaccination.\":\"Diagramme à barres empilées de la proportion de pays ayant mis en œuvre des stratégies comportementales ou sociales pour lutter contre la sous-vaccination\",\"With a behavioural and social drivers of vaccination\":\"Avec stratégie comportementale ou sociale\",\"Without a behavioural and social drivers of vaccination\":\"Sans stratégie comportementale ou sociale\",\"A table that lists the proportion of countries that have implemented behavioural or social strategies to address under-vaccination.\":\"Un tableau qui répertorie la proportion de pays qui ont mis en œuvre des stratégies comportementales ou sociales pour lutter contre la sous-vaccination\",\"Bar chart showing coverage in the 20% of districts with the lowest coverage - by country for\":\"Diagramme à barres montrant la couverture dans les 20 % de districts ayant la couverture la plus faible - par pays pour\",\"antigen\":\"Antigène\",\"A table that lists the percentage of DTP3, MCV1, and MCV2 coverage in the 20% of districts with the lowest coverage - by year.\":\"Un tableau qui répertorie le pourcentage de couverture par le DTC3, le MCV1 et le MCV2 dans les 20% des districts ayant la couverture la plus faible - par année\",\"coverage rate\":\"taux de couverture\",\"in\":\"en\",\"Bar chart showing percentage of protection - mean across 12 antigens - by year for\":\"Diagramme à barres montrant le pourcentage de protection - moyenne sur 12 antigènes - par année pour\",\"HEPB3\":\"HEPB3\",\"HIB3\":\"HIB3\",\"IPV1\":\"IPV1\",\"POL3\":\"POL3\",\"RCV1\":\"RCV1\",\"ROTAC\":\"ROTAC\",\"DTP3-SP41\":\"3e dose de vaccin contenant de la diphtérie, du tétanos et de la coqueluche (DTC3)\",\"HEPB3-SP41\":\"3e dose de vaccin contre l'hépatite B (HepB3)\",\"HIB3-SP41\":\"3e dose de vaccin contre l'Haemophilus influenzae de type b (Hib3)\",\"HPVc-SP41\":\"Dernière dose du vaccin contre le papillomavirus humain (VPH)\",\"IPV1-SP41\":\"1re dose de vaccin antipoliomyélitique inactivé (VPI1)\",\"MCV1-SP41\":\"1re dose du vaccin antirougeloeux (VAR1)\",\"MCV2-SP41\":\"2e dose du vaccin antirougeloeux (VAR2)\",\"PCV3-SP41\":\"3e dose de vaccin pneumococcique conjugué (VPC3)\",\"POL3-SP41\":\"3e dose de vaccin antipoliomyélitique (POL3)\",\"RCV1-SP41\":\"1re dose de vaccin contenant la rubéole (VCR1)\",\"ROTAC-SP41\":\"Dernière dose de la série de vaccins rotavirus (ROTAC)\",\"BOP-SP41\":\"Couverture Moyenne\",\"A table that lists the percentage of protection of 12 antigens - by year\":\"Un tableau qui répertorie le pourcentage de protection de 12 antigènes - par année\",\"timely\":\"En temps opportun\",\"untimely\":\"Intempestif\",\"Stacked bar chart of proportion of outbreaks with timely detection and response.\":\"Diagramme à barres empilées de la proportion de foyers épidémiques ayant été détectés et traités en temps utile\",\"outbreaks with timely detection and response\":\"Les foyers épidémiques avec une détection et une réponse rapides\",\"A table that lists the number of outbreaks with timely detection and response.\":\"Un tableau qui répertorie le nombre de foyers épidémiques ayant fait l'objet d'une détection et d'une intervention en temps utile\",\"Bacille Calmette-Guerin (BCG)\":\"Bacille Calmette-Guerin (BCG)\",\"Human papillomavirus (HPV)\":\"Papillomavirus humain (PVH)\",\"Pneumococcal conjugate vaccine (PCV)\":\"Vaccin antipneumococcique conjugué (VPC)\",\"Pneumococcal polysaccharide\":\"Antipneumococcique polysaccharide\",\"Measles-rubella\":\"Rougeole-Rubéole\",\"Measles-mumps-rubella (MMR)\":\"Rougeole – Oreillons – Rubéole (ROR)\",\"Penta (whole-cell pertussis-containing)\":\"Penta (contenant la coqueluche à cellule entière)\",\"Hexa (acellular pertussis-containing)\":\"Hexa (contenant la coqueluche acellulaire)\",\"Tetanus-diphtheria\":\"Tétanos-Diphtérie\",\"Inactivated polio vaccine, stand-alone\":\"Vaccin anti-poliomyélitique inactivé, monovalent\",\"Unhealthy\":\"Malsain\",\"Concerning\":\"Inquiétant\",\"Healthy\":\"Sain\",\"Not applicable\":\"Sans objet\",\"Increasing expenditure level\":\"Augmentation du niveau des dépenses\",\"Stable expenditure level\":\"Niveau de dépenses stable\",\"Declining expenditure level\":\"Baisse du niveau des dépenses\",\"Stacked bar chart showing proportion of countries whose domestic government and donor expenditure on primary health care increased or remained stable.\":\"Diagramme à barres empilées montrant la proportion de pays dont les dépenses des gouvernements nationaux et des donateurs pour les soins de santé primaires ont augmenté ou sont restées stables\",\"A table that lists the proportion of countries whose domestic government and donor expenditure on primary health care increased or remained stable.\":\"Un tableau qui répertorie la proportion de pays dont les dépenses des gouvernements nationaux et des donateurs en matière de soins de santé primaires ont augmenté ou sont restées stables\",\"Increased share\":\"Part augmentée\",\"Stable share\":\"Part stable\",\"Decreased share\":\"Part diminuée\",\"Stacked bar chart showing proportion of countries whose share of national immunization schedule vaccine expenditure funded by domestic government resources increased or remained stable.\":\"Diagramme à barres empilées montrant la proportion de pays dont la part des dépenses de vaccination du calendrier national de vaccination financée par des ressources publiques nationales a augmenté ou est restée stable\",\"A table that lists the proportion of countries whose share of national immunization schedule vaccine expenditure funded by domestic government resources increased or remained stable.\":\"Un tableau qui répertorie la proportion de pays dont la part des dépenses de vaccination du calendrier national de vaccination financée par des ressources gouvernementales nationales a augmenté ou est restée stable\",\"Stacked bar chart of proportion of countries with an immunization research agenda.\":\"Diagramme à barres empilées de la proportion de pays ayant un programme de recherche sur la vaccination\",\"With an immunization research agenda\":\"Avec un programme de recherche sur la vaccination\",\"Without an immunization research agenda\":\"Sans un programme de recherche sur la vaccination\",\"A table that lists the proportion of countries with an immunization research agenda.\":\"Un tableau qui répertorie la proportion de pays ayant un programme de recherche sur la vaccination\",\"download pdf\":\"Télécharger le rapport pays - IA2030\",\"press the X to reset to regional comparisons\":\"Appuyez sur le X pour revenir aux comparaisons régionales\",\"compare against another country\":\"Comparer avec un autre pays\",\"region\":\"Région\",\"learn more\":\"En savoir plus\",\"not measured at the country level\":\"Non mesuré au niveau du pays\",\"not measured at the regional level\":\"Non mesuré au niveau régional\",\"no target\":\"Pas de cible\",\"no data\":\"Pas de données\",\"reached\":\"Atteint\",\"not reached\":\"Non atteint\",\"not shown at the country level\":\"Non montré au niveau du pays\",\"not shown at the regional level\":\"Non indiqué au niveau régional\",\"not measured in this country\":\"Non mesuré dans ce pays\",\"not measured in this region\":\"Non mesuré dans cette région\",\"not applicable\":\"Sans objet\",\"data not available\":\"Data not available\",\"how to read the indicators\":\"Comment lire les indicateurs\",\"yes\":\"Oui\",\"no\":\"Non\",\"country achieved strategic priority\":\"Le pays a atteint la priorité stratégique\",\"country did not achieve strategic priority\":\"Le pays n'a pas atteint la priorité stratégique\",\"country did not report data or data is not available\":\"Le pays n'a pas rapporté de données ou les données ne sont pas disponibles\",\"Global — All Regions\":\"Global - toutes les régions\",\"WHO African Region\":\"Région africaine de l'OMS\",\"WHO Region of the Americas\":\"Région OMS des Amériques\",\"WHO Eastern Mediterranean Region\":\"Région méditerranéenne orientale de l'OMS\",\"WHO European Region\":\"Région européenne de l'OMS\",\"WHO South-East Asian Region\":\"Région de l'Asie du Sud-Est de l'OMS\",\"WHO Western Pacific Region\":\"Région du Pacifique occidental de l'OMS\",\"WB Low Income Countries\":\"Pays à faible revenu de la Banque mondiale\",\"WB Lower-Middle Income Countries\":\"Banque mondiale, pays à revenu intermédiaire de la tranche inférieure \",\"WB Upper-Middle Income Countries\":\"Pays à revenu intermédiaire de la tranche supérieure de la Banque mondiale\",\"WB High Income Countries\":\"Pays à haut revenu de la Banque mondiale\",\"UNICEF East Asia and Pacific Region\":\"Région Asie de l'Est et Pacifique de l’UNICEF\",\"UNICEF Europe and Central Asia Region\":\"Régional pour l'Europe et l'Asie centrale de l’UNICEF\",\"UNICEF Eastern and Southern Africa Region\":\"Régional pour l'Afrique de l'Est et australe de l’UNICEF\",\"UNICEF Latin America and the Caribbean Region\":\"Régional pour l'Amérique latine et les Caraïbes de l’UNICEF\",\"UNICEF Middle East and North Africa Region\":\"Régional pour le Moyen-Orient et l'Afrique du Nord de l’UNICEF\",\"UNICEF South Asia Region\":\"Régional pour l'Asie du Sud de l’UNICEF\",\"UNICEF West and Central Africa Region\":\"Régional pour l'Afrique de l'Ouest et centrale de l’UNICEF\",\"WHO Region\":\"Région de l'OMS\",\"UNICEF Programme Region\":\"Région de programme de l'UNICEF\",\"World Bank Income Group\":\"Groupe de revenu de la Banque mondiale\",\"African Region\":\"Région africaine\",\"Region of the Americas\":\"Région des Amériques\",\"Eastern Mediterranean Region\":\"Région méditerranéenne orientale\",\"European Region\":\"Région européenne\",\"South-East Asian Region\":\"Région de l'Asie du Sud-Est\",\"Western Pacific Region\":\"Région du Pacifique occidental\",\"Low Income\":\"Faible revenu\",\"Low-Middle Income\":\"Revenu intermédiaire de la tranche inférieure\",\"Upper-Middle Income\":\"Revenu intermédiaire de la tranche supérieure\",\"High Income\":\"Haut revenu\",\"East Asia and Pacific Region\":\"Région Asie de l'Est et Pacifique\",\"Europe and Central Asia Region\":\"Régional pour l'Europe et l'Asie centrale\",\"Eastern and Southern Africa Region\":\"Régional pour l'Afrique de l'Est et australe\",\"Latin America and the Caribbean Region\":\"Régional pour l'Amérique latine et les Caraïbes\",\"Middle East and North Africa Region\":\"Régional pour le Moyen-Orient et l'Afrique du Nord\",\"South Asia Region\":\"Régional pour l'Asie du Sud\",\"West and Central Africa Region\":\"Régional pour l'Afrique de l'Ouest et centrale\",\"WHO Regions\":\"Régions de l'OMS\",\"UNICEF Programme Regions\":\"Régions du programme de l'UNICEF\",\"World Bank Income Classification\":\"Classification des revenus de la Banque mondiale\",\"See the countries in\":\"Voir les pays de\",\"Afghanistan\":\"Afghanistan\",\"Albania\":\"Albanie\",\"Algeria\":\"Algérie\",\"Andorra\":\"Andorre\",\"Angola\":\"Angola\",\"Antigua and Barbuda\":\"Antigua et Barbuda\",\"Argentina\":\"Argentine\",\"Armenia\":\"Arménie\",\"Australia\":\"Australie\",\"Austria\":\"Autriche\",\"Azerbaijan\":\"Azerbaïdjan\",\"Bahamas\":\"Bahamas\",\"Bahrain\":\"Bahreïn\",\"Bangladesh\":\"Bangladesh\",\"Barbados\":\"Barbade\",\"Belarus\":\"Bélarus\",\"Belgium\":\"Belgique\",\"Belize\":\"Belize\",\"Benin\":\"Bénin\",\"Bhutan\":\"Bhoutan\",\"Bolivia (Plurinational State of)\":\"Bolivie (État plurinational de)\",\"Bosnia and Herzegovina\":\"Bosnie-Herzégovine\",\"Botswana\":\"Botswana\",\"Brazil\":\"Brésil\",\"Brunei Darussalam\":\"Brunei Darussalam\",\"Bulgaria\":\"Bulgarie\",\"Burkina Faso\":\"Burkina Faso\",\"Burundi\":\"Burundi\",\"Cambodia\":\"Cambodge\",\"Cameroon\":\"Cameroun\",\"Canada\":\"Canada\",\"Cabo Verde\":\"Cabo Verde\",\"Central African Republic\":\"République centrafricaine\",\"Chad\":\"Tchad\",\"Chile\":\"Chili\",\"China\":\"Chine\",\"Colombia\":\"Colombie\",\"Comoros\":\"Comores\",\"Congo\":\"Congo\",\"Cook Islands\":\"Îles Cook\",\"Costa Rica\":\"Costa Rica\",\"Côte d'Ivoire\":\"Côte d'Ivoire\",\"Croatia\":\"Croatie\",\"Cuba\":\"Cuba\",\"Cyprus\":\"Chypre\",\"Czechia\":\"Tchéquie\",\"Democratic People's Republic of Korea\":\"République populaire démocratique de Corée\",\"Democratic Republic of the Congo\":\"République démocratique du Congo\",\"Denmark\":\"Danemark\",\"Djibouti\":\"Djibouti\",\"Dominica\":\"Dominique\",\"Dominican Republic\":\"République dominicaine\",\"Ecuador\":\"Équateur\",\"Egypt\":\"Égypte\",\"El Salvador\":\"El Salvador\",\"Equatorial Guinea\":\"Guinée équatoriale\",\"Eritrea\":\"Érythrée\",\"Estonia\":\"Estonie\",\"Eswatini\":\"Eswatini\",\"Ethiopia\":\"Ethiopie\",\"Fiji\":\"Fidji\",\"Finland\":\"Finlande\",\"France\":\"France\",\"Gabon\":\"Gabon\",\"Gambia\":\"Gambie\",\"Georgia\":\"Géorgie\",\"Germany\":\"Allemagne\",\"Ghana\":\"Ghana\",\"Greece\":\"Grèce\",\"Grenada\":\"Grenade\",\"Guatemala\":\"Guatemala\",\"Guinea\":\"Guinée\",\"Guinea-Bissau\":\"Guinée-Bissau\",\"Guyana\":\"Guyane\",\"Haiti\":\"Haïti\",\"Honduras\":\"Honduras\",\"Hungary\":\"Hongrie\",\"Iceland\":\"Islande\",\"India\":\"Inde\",\"Indonesia\":\"Indonésie\",\"Iran (Islamic Republic of) \":\"Iran (République islamique d')\",\"Iraq\":\"Iraq\",\"Ireland\":\"Irlande\",\"Israel\":\"Israël\",\"Italy\":\"Italie\",\"Jamaica\":\"Jamaïque\",\"Japan\":\"Japon\",\"Jordan\":\"Jordanie\",\"Kazakhstan\":\"Kazakhstan\",\"Kenya\":\"Kenya\",\"Kiribati\":\"Kiribati\",\"Kuwait\":\"Koweït\",\"Kyrgyzstan\":\"Kirghizistan\",\"Lao People's Democratic Republic\":\"République démocratique populaire lao\",\"Latvia\":\"Lettonie\",\"Lebanon\":\"Liban\",\"Lesotho\":\"Lesotho\",\"Liberia\":\"Libéria\",\"Libya\":\"Libye\",\"Lithuania\":\"Lituanie\",\"Luxembourg\":\"Luxembourg\",\"Madagascar\":\"Madagascar\",\"Malawi\":\"Malawi\",\"Malaysia\":\"Malaisie\",\"Maldives\":\"Maldives\",\"Mali\":\"Mali\",\"Malta\":\"Malte\",\"Marshall Islands\":\"Îles Marshall\",\"Mauritania\":\"Mauritanie\",\"Mauritius\":\"Maurice\",\"Mexico\":\"Mexique\",\"Micronesia (Federated States of)\":\"Micronésie (États fédérés de)\",\"Monaco\":\"Monaco\",\"Mongolia\":\"Mongolie\",\"Montenegro\":\"Monténégro\",\"Morocco\":\"Maroc\",\"Mozambique\":\"Mozambique\",\"Myanmar\":\"Myanmar\",\"Namibia\":\"Namibie\",\"Nauru\":\"Nauru\",\"Nepal\":\"Népal\",\"Netherlands (Kingdom of the)\":\"Pays-Bas (Royaume des)\",\"New Zealand\":\"Nouvelle-Zélande\",\"Nicaragua\":\"Nicaragua\",\"Niger\":\"Niger\",\"Nigeria\":\"Nigéria\",\"Niue\":\"Nioué\",\"North Macedonia\":\"Macédoine du Nord\",\"Norway\":\"Norvège\",\"Oman\":\"Oman\",\"Pakistan\":\"Pakistan\",\"Palau\":\"Palaos\",\"Panama\":\"Panama\",\"Papua New Guinea\":\"Papouasie-Nouvelle-Guinée\",\"Paraguay\":\"Paraguay\",\"Peru\":\"Pérou\",\"Philippines\":\"Philippines\",\"Poland\":\"Pologne\",\"Portugal\":\"Portugal\",\"Qatar\":\"Qatar\",\"Republic of Korea\":\"République de Corée\",\"Republic of Moldova\":\"République de Moldava\",\"Romania\":\"Roumanie\",\"Russian Federation\":\"Fédération de Russie\",\"Rwanda\":\"Rwanda\",\"Saint Kitts and Nevis\":\"Saint-Kitts-et-Nevis\",\"Saint Lucia\":\"Sainte-Lucie\",\"Saint Vincent and the Grenadines\":\"Saint-Vincent-et-les-Grenadines\",\"Samoa\":\"Samoa\",\"San Marino\":\"Saint-Marin\",\"Sao Tome and Principe\":\"Sao Tomé-et-Principe\",\"Saudi Arabia\":\"Arabie Saoudite\",\"Senegal\":\"Sénégal\",\"Serbia\":\"Serbie\",\"Seychelles\":\"Seychelles\",\"Sierra Leone\":\"Sierra Leone\",\"Singapore\":\"Singapour\",\"Slovakia\":\"Slovaquie\",\"Slovenia\":\"Slovénie\",\"Solomon Islands\":\"Îles Salomon\",\"Somalia\":\"Somalie\",\"South Africa\":\"Afrique du Sud\",\"South Sudan\":\"Soudan du Sud\",\"Spain\":\"Espagne\",\"Sri Lanka\":\"Sri Lanka\",\"Sudan\":\"Soudan\",\"Suriname\":\"Suriname\",\"Sweden\":\"Suède\",\"Switzerland\":\"Suisse\",\"Syrian Arab Republic\":\"République arabe syrienne\",\"Tajikistan\":\"Tadjikistan\",\"Thailand\":\"Thaïlande\",\"Timor-Leste\":\"Timor-Leste\",\"Togo\":\"Togo\",\"Tonga\":\"Tonga\",\"Trinidad and Tobago\":\"Trinité-et-Tobago\",\"Tunisia\":\"Tunisie\",\"Turkey\":\"Turquie\",\"Turkmenistan\":\"Turkménistan\",\"Tuvalu\":\"Tuvalu\",\"Uganda\":\"Ouganda\",\"Ukraine\":\"Ukraine\",\"United Arab Emirates\":\"Émirats arabes unis\",\"United Kingdom of Great Britain and Northern Ireland\":\"Royaume-Uni de Grande-Bretagne et d'Irlande du Nord\",\"United Republic of Tanzania\":\"République-Unie de Tanzanie\",\"United States of America\":\"États-Unis d'Amérique\",\"Uruguay\":\"Uruguay\",\"Uzbekistan\":\"Ouzbékistan\",\"Vanuatu\":\"Vanuatu\",\"Venezuela (Bolivarian Republic of)\":\"Venezuela (République bolivarienne du)\",\"Viet Nam\":\"Viet Nam\",\"Yemen\":\"Yémen\",\"Zambia\":\"Zambie\",\"Zimbabwe\":\"Zimbabwe\",\"accessed\":\"Accédé\",\"Immunization Agenda 2030\":\"Programme de vaccination 2030\",\"disclaimer\":\"Les 194 États membres de l’OMS sont pris en compte. Les Îles Cook et Niue sont exclues de la ventilation par groupe de revenu de la Banque mondiale, car elles ne sont pas classées. Le Venezuela n'est temporairement pas classé par la Banque mondiale, mais déclaré comme Pays à revenu intermédiaire supérieur selon la classification de 2019.\"}","language":"fr"}}]},"content":{"igDataIntroRt":"<p><strong>Cette page affiche les données les plus récentes disponibles pour ce pays.</strong></p>","ig11Description":"Nombre de décès futurs évités grâce à la vaccination","ig12Description":"Réalisation des objectifs de contrôle, d'élimination et d'éradication des MEV","ig13Description":"Nombre d’épidémies importantes ou perturbatrices de MEV","ig21Description":"Ne laisser aucun enfant pour compte - Nombre d'enfants à zéro dose de vaccin","ig21Disclaimer":"Les données au niveau du pays sont calculées à l'aide des sources et de la méthodologie ci-dessous, les valeurs peuvent différer des estimations utilisant les données gérées par le pays.  Les valeurs sont arrondies aux milliers.","ig22Description":"Introduction de vaccins nouveaux ou sous-utilisés dans les pays à revenu faible ou intermédiaire","ig31Description":"Couverture vaccinale tout au long de la vie","ig32Description":"Renforcer la couverture sanitaire universelle (CSU) - Indice de couverture des services aux CSU","spDataIntroRt":"<p><strong>Le Programme de vaccination 2030 comprend sept priorités stratégiques. Il est nécessaire d'agir dans tous les domaines pour que la vaccination contribue pleinement au renforcement des soins de santé primaires et à l’atteinte de la couverture sanitaire universelle.</strong></p>","sp11Description":"Existence rapportée d'un GTCV fonctionnel","sp12Description":"Densité pour 10 000 habitants","sp13Description":"Objectifs atteints pour un taux de cas écartés pour les maladies non liées à la rougeole et à la rubéole et un taux de paralysie flasque aiguë non liée à la polio","sp14Description":"Pays connaissant des ruptures de stock au niveau des districts","sp16Description":"Au moins un rapport de sécurité documenté sur un cas individuel grave de MAPI par million d'habitants","sp21Description":"Législation en place favorable à la vaccination comme un bien public","sp22Description":"Stratégies comportementales ou sociales mises en œuvre pour lutter contre la sous-vaccination.","sp32Description":"Couverture dans les 20 % de districts affichant les taux de couverture les plus faibles  ","sp41Description":"Vaccination au cours de la vie - étendue de la protection (moyenne entre les antigènes)","sp51Description":"Proportion d’épidémies détectées et traitées en temps réel","sp61Description":"Niveau de santé du marché des vaccins","sp62Description":"Les dépenses du gouvernement national et des donateurs pour les soins de santé primaires ont augmenté ou sont restées stables","sp63Description":"La part des dépenses liées aux vaccins du programme national de vaccination financée par des ressources publiques nationales a augmenté","sp71Description":"Possède un programme de recherche sur la vaccination","sp72Description":"Progrès vers la recherche et développement au niveau mondial"},"footerContent":{"citationRt":"<p><strong>Cette ressource est librement utilisable selon la licence Creative Commons: <a href=\"https://creativecommons.org/licenses/by/4.0/\" rel=\"noopener noreferrer\" target=\"_blank\">Attribution 4.0 International</a>. </strong></p><br/><span><strong>Citation : Tableau de bord du programme de vaccination (IA2030) Scorecard. scorecard.immunizationagenda2030.org. </strong></span>","descriptionRt":"<p>Le tableau de bord IA2030 visualise les indicateurs de suivi et d'évaluation du <a href=\"https://www.who.int/teams/immunization-vaccines-and-biologicals/strategies/ia2030\" rel=\"noopener noreferrer\" target=\"_blank\">Cadre d'action IA2030</a> pprouvé en 2020 par l'Assemblée mondiale de la Santé, avec le soutien des pays et des partenaires. Le tableau de bord est un effort de collaboration mené par MOMENTUM Country and Global Leadership, en partenariat avec les groupes de travail IA2030 sur le suivi et l'évaluation et sur la communication et le plaidoyer, sous la supervision du Secrétariat IA2030 et du Groupe de coordination IA2030 (IACG). <a href=\"https://docs.google.com/forms/d/e/1FAIpQLScAVyd2NGFEegfOzRnI_MAoo_jEqsqr200Y3lE8tdAFv4J_4g/viewform\" rel=\"noopener noreferrer\" target=\"_blank\">Partagez vos commentaires ici.</a></p>"},"countryList":{"nodes":[{"COUNTRY":"CHN","COUNTRY_NAME":"China"},{"COUNTRY":"ALB","COUNTRY_NAME":"Albania"},{"COUNTRY":"MLT","COUNTRY_NAME":"Malta"},{"COUNTRY":"SDN","COUNTRY_NAME":"Sudan"},{"COUNTRY":"ATG","COUNTRY_NAME":"Antigua and Barbuda"},{"COUNTRY":"NOR","COUNTRY_NAME":"Norway"},{"COUNTRY":"SVK","COUNTRY_NAME":"Slovakia"},{"COUNTRY":"VUT","COUNTRY_NAME":"Vanuatu"},{"COUNTRY":"MHL","COUNTRY_NAME":"Marshall Islands"},{"COUNTRY":"DZA","COUNTRY_NAME":"Algeria"},{"COUNTRY":"HND","COUNTRY_NAME":"Honduras"},{"COUNTRY":"THA","COUNTRY_NAME":"Thailand"},{"COUNTRY":"SLE","COUNTRY_NAME":"Sierra Leone"},{"COUNTRY":"SVN","COUNTRY_NAME":"Slovenia"},{"COUNTRY":"KAZ","COUNTRY_NAME":"Kazakhstan"},{"COUNTRY":"TKM","COUNTRY_NAME":"Turkmenistan"},{"COUNTRY":"PRY","COUNTRY_NAME":"Paraguay"},{"COUNTRY":"VCT","COUNTRY_NAME":"Saint Vincent and the Grenadines"},{"COUNTRY":"BRB","COUNTRY_NAME":"Barbados"},{"COUNTRY":"PLW","COUNTRY_NAME":"Palau"},{"COUNTRY":"ARM","COUNTRY_NAME":"Armenia"},{"COUNTRY":"IRL","COUNTRY_NAME":"Ireland"},{"COUNTRY":"IRN","COUNTRY_NAME":"Iran (Islamic Republic of)"},{"COUNTRY":"AUS","COUNTRY_NAME":"Australia"},{"COUNTRY":"QAT","COUNTRY_NAME":"Qatar"},{"COUNTRY":"SEN","COUNTRY_NAME":"Senegal"},{"COUNTRY":"PRK","COUNTRY_NAME":"Democratic People's Republic of Korea"},{"COUNTRY":"BOL","COUNTRY_NAME":"Bolivia (Plurinational State of)"},{"COUNTRY":"FRA","COUNTRY_NAME":"France"},{"COUNTRY":"FSM","COUNTRY_NAME":"Micronesia (Federated States of)"},{"COUNTRY":"GHA","COUNTRY_NAME":"Ghana"},{"COUNTRY":"POL","COUNTRY_NAME":"Poland"},{"COUNTRY":"PRT","COUNTRY_NAME":"Portugal"},{"COUNTRY":"STP","COUNTRY_NAME":"Sao Tome and Principe"},{"COUNTRY":"GNQ","COUNTRY_NAME":"Equatorial Guinea"},{"COUNTRY":"EST","COUNTRY_NAME":"Estonia"},{"COUNTRY":"NIC","COUNTRY_NAME":"Nicaragua"},{"COUNTRY":"BRN","COUNTRY_NAME":"Brunei Darussalam"},{"COUNTRY":"NGA","COUNTRY_NAME":"Nigeria"},{"COUNTRY":"BDI","COUNTRY_NAME":"Burundi"},{"COUNTRY":"SYC","COUNTRY_NAME":"Seychelles"},{"COUNTRY":"IND","COUNTRY_NAME":"India"},{"COUNTRY":"LCA","COUNTRY_NAME":"Saint Lucia"},{"COUNTRY":"COM","COUNTRY_NAME":"Comoros"},{"COUNTRY":"SYR","COUNTRY_NAME":"Syrian Arab Republic"},{"COUNTRY":"MDG","COUNTRY_NAME":"Madagascar"},{"COUNTRY":"PAK","COUNTRY_NAME":"Pakistan"},{"COUNTRY":"SSD","COUNTRY_NAME":"South Sudan"},{"COUNTRY":"MCO","COUNTRY_NAME":"Monaco"},{"COUNTRY":"NER","COUNTRY_NAME":"Niger"},{"COUNTRY":"ETH","COUNTRY_NAME":"Ethiopia"},{"COUNTRY":"BHS","COUNTRY_NAME":"Bahamas"},{"COUNTRY":"HTI","COUNTRY_NAME":"Haiti"},{"COUNTRY":"KEN","COUNTRY_NAME":"Kenya"},{"COUNTRY":"TCD","COUNTRY_NAME":"Chad"},{"COUNTRY":"YEM","COUNTRY_NAME":"Yemen"},{"COUNTRY":"COG","COUNTRY_NAME":"Congo"},{"COUNTRY":"BGD","COUNTRY_NAME":"Bangladesh"},{"COUNTRY":"ESP","COUNTRY_NAME":"Spain"},{"COUNTRY":"LUX","COUNTRY_NAME":"Luxembourg"},{"COUNTRY":"LBY","COUNTRY_NAME":"Libya"},{"COUNTRY":"DJI","COUNTRY_NAME":"Djibouti"},{"COUNTRY":"JOR","COUNTRY_NAME":"Jordan"},{"COUNTRY":"ISL","COUNTRY_NAME":"Iceland"},{"COUNTRY":"AUT","COUNTRY_NAME":"Austria"},{"COUNTRY":"BRA","COUNTRY_NAME":"Brazil"},{"COUNTRY":"TUR","COUNTRY_NAME":"Türkiye"},{"COUNTRY":"USA","COUNTRY_NAME":"United States of America"},{"COUNTRY":"MWI","COUNTRY_NAME":"Malawi"},{"COUNTRY":"SOM","COUNTRY_NAME":"Somalia"},{"COUNTRY":"LKA","COUNTRY_NAME":"Sri Lanka"},{"COUNTRY":"DMA","COUNTRY_NAME":"Dominica"},{"COUNTRY":"TZA","COUNTRY_NAME":"United Republic of Tanzania"},{"COUNTRY":"RWA","COUNTRY_NAME":"Rwanda"},{"COUNTRY":"NRU","COUNTRY_NAME":"Nauru"},{"COUNTRY":"TTO","COUNTRY_NAME":"Trinidad and Tobago"},{"COUNTRY":"MMR","COUNTRY_NAME":"Myanmar"},{"COUNTRY":"MOZ","COUNTRY_NAME":"Mozambique"},{"COUNTRY":"TUN","COUNTRY_NAME":"Tunisia"},{"COUNTRY":"TLS","COUNTRY_NAME":"Timor-Leste"},{"COUNTRY":"CZE","COUNTRY_NAME":"Czechia"},{"COUNTRY":"SWZ","COUNTRY_NAME":"Eswatini"},{"COUNTRY":"MDA","COUNTRY_NAME":"Republic of Moldova"},{"COUNTRY":"MNG","COUNTRY_NAME":"Mongolia"},{"COUNTRY":"PHL","COUNTRY_NAME":"Philippines"},{"COUNTRY":"SLV","COUNTRY_NAME":"El Salvador"},{"COUNTRY":"HUN","COUNTRY_NAME":"Hungary"},{"COUNTRY":"SWE","COUNTRY_NAME":"Sweden"},{"COUNTRY":"TGO","COUNTRY_NAME":"Togo"},{"COUNTRY":"PAN","COUNTRY_NAME":"Panama"},{"COUNTRY":"TJK","COUNTRY_NAME":"Tajikistan"},{"COUNTRY":"BHR","COUNTRY_NAME":"Bahrain"},{"COUNTRY":"GMB","COUNTRY_NAME":"Gambia"},{"COUNTRY":"ERI","COUNTRY_NAME":"Eritrea"},{"COUNTRY":"GIN","COUNTRY_NAME":"Guinea"},{"COUNTRY":"ECU","COUNTRY_NAME":"Ecuador"},{"COUNTRY":"EGY","COUNTRY_NAME":"Egypt"},{"COUNTRY":"MAR","COUNTRY_NAME":"Morocco"},{"COUNTRY":"BFA","COUNTRY_NAME":"Burkina Faso"},{"COUNTRY":"ITA","COUNTRY_NAME":"Italy"},{"COUNTRY":"LTU","COUNTRY_NAME":"Lithuania"},{"COUNTRY":"DOM","COUNTRY_NAME":"Dominican Republic"},{"COUNTRY":"GNB","COUNTRY_NAME":"Guinea-Bissau"},{"COUNTRY":"GUY","COUNTRY_NAME":"Guyana"},{"COUNTRY":"NLD","COUNTRY_NAME":"Netherlands (Kingdom of the)"},{"COUNTRY":"KNA","COUNTRY_NAME":"Saint Kitts and Nevis"},{"COUNTRY":"PNG","COUNTRY_NAME":"Papua New Guinea"},{"COUNTRY":"KIR","COUNTRY_NAME":"Kiribati"},{"COUNTRY":"TUV","COUNTRY_NAME":"Tuvalu"},{"COUNTRY":"BTN","COUNTRY_NAME":"Bhutan"},{"COUNTRY":"AZE","COUNTRY_NAME":"Azerbaijan"},{"COUNTRY":"SMR","COUNTRY_NAME":"San Marino"},{"COUNTRY":"GEO","COUNTRY_NAME":"Georgia"},{"COUNTRY":"ZMB","COUNTRY_NAME":"Zambia"},{"COUNTRY":"NZL","COUNTRY_NAME":"New Zealand"},{"COUNTRY":"AND","COUNTRY_NAME":"Andorra"},{"COUNTRY":"CAF","COUNTRY_NAME":"Central African Republic"},{"COUNTRY":"ARG","COUNTRY_NAME":"Argentina"},{"COUNTRY":"UZB","COUNTRY_NAME":"Uzbekistan"},{"COUNTRY":"LSO","COUNTRY_NAME":"Lesotho"},{"COUNTRY":"AFG","COUNTRY_NAME":"Afghanistan"},{"COUNTRY":"COK","COUNTRY_NAME":"Cook Islands"},{"COUNTRY":"URY","COUNTRY_NAME":"Uruguay"},{"COUNTRY":"VEN","COUNTRY_NAME":"Venezuela (Bolivarian Republic of)"},{"COUNTRY":"SRB","COUNTRY_NAME":"Serbia"},{"COUNTRY":"FIN","COUNTRY_NAME":"Finland"},{"COUNTRY":"NPL","COUNTRY_NAME":"Nepal"},{"COUNTRY":"JPN","COUNTRY_NAME":"Japan"},{"COUNTRY":"UGA","COUNTRY_NAME":"Uganda"},{"COUNTRY":"CMR","COUNTRY_NAME":"Cameroon"},{"COUNTRY":"ROU","COUNTRY_NAME":"Romania"},{"COUNTRY":"SGP","COUNTRY_NAME":"Singapore"},{"COUNTRY":"GTM","COUNTRY_NAME":"Guatemala"},{"COUNTRY":"BLR","COUNTRY_NAME":"Belarus"},{"COUNTRY":"BGR","COUNTRY_NAME":"Bulgaria"},{"COUNTRY":"VNM","COUNTRY_NAME":"Viet Nam"},{"COUNTRY":"LBN","COUNTRY_NAME":"Lebanon"},{"COUNTRY":"CRI","COUNTRY_NAME":"Costa Rica"},{"COUNTRY":"BWA","COUNTRY_NAME":"Botswana"},{"COUNTRY":"UKR","COUNTRY_NAME":"Ukraine"},{"COUNTRY":"CUB","COUNTRY_NAME":"Cuba"},{"COUNTRY":"FJI","COUNTRY_NAME":"Fiji"},{"COUNTRY":"BEL","COUNTRY_NAME":"Belgium"},{"COUNTRY":"LVA","COUNTRY_NAME":"Latvia"},{"COUNTRY":"HRV","COUNTRY_NAME":"Croatia"},{"COUNTRY":"MNE","COUNTRY_NAME":"Montenegro"},{"COUNTRY":"DNK","COUNTRY_NAME":"Denmark"},{"COUNTRY":"MLI","COUNTRY_NAME":"Mali"},{"COUNTRY":"COL","COUNTRY_NAME":"Colombia"},{"COUNTRY":"CAN","COUNTRY_NAME":"Canada"},{"COUNTRY":"AGO","COUNTRY_NAME":"Angola"},{"COUNTRY":"MRT","COUNTRY_NAME":"Mauritania"},{"COUNTRY":"CHL","COUNTRY_NAME":"Chile"},{"COUNTRY":"ZAF","COUNTRY_NAME":"South Africa"},{"COUNTRY":"GRC","COUNTRY_NAME":"Greece"},{"COUNTRY":"BIH","COUNTRY_NAME":"Bosnia and Herzegovina"},{"COUNTRY":"IRQ","COUNTRY_NAME":"Iraq"},{"COUNTRY":"LAO","COUNTRY_NAME":"Lao People's Democratic Republic"},{"COUNTRY":"KOR","COUNTRY_NAME":"Republic of Korea"},{"COUNTRY":"GAB","COUNTRY_NAME":"Gabon"},{"COUNTRY":"BLZ","COUNTRY_NAME":"Belize"},{"COUNTRY":"KGZ","COUNTRY_NAME":"Kyrgyzstan"},{"COUNTRY":"COD","COUNTRY_NAME":"Democratic Republic of the Congo"},{"COUNTRY":"NAM","COUNTRY_NAME":"Namibia"},{"COUNTRY":"IDN","COUNTRY_NAME":"Indonesia"},{"COUNTRY":"MEX","COUNTRY_NAME":"Mexico"},{"COUNTRY":"MUS","COUNTRY_NAME":"Mauritius"},{"COUNTRY":"SUR","COUNTRY_NAME":"Suriname"},{"COUNTRY":"KHM","COUNTRY_NAME":"Cambodia"},{"COUNTRY":"RUS","COUNTRY_NAME":"Russian Federation"},{"COUNTRY":"JAM","COUNTRY_NAME":"Jamaica"},{"COUNTRY":"ZWE","COUNTRY_NAME":"Zimbabwe"},{"COUNTRY":"CIV","COUNTRY_NAME":"Côte d'Ivoire"},{"COUNTRY":"ISR","COUNTRY_NAME":"Israel"},{"COUNTRY":"PER","COUNTRY_NAME":"Peru"},{"COUNTRY":"MYS","COUNTRY_NAME":"Malaysia"},{"COUNTRY":"CHE","COUNTRY_NAME":"Switzerland"},{"COUNTRY":"GRD","COUNTRY_NAME":"Grenada"},{"COUNTRY":"CPV","COUNTRY_NAME":"Cabo Verde"},{"COUNTRY":"WSM","COUNTRY_NAME":"Samoa"},{"COUNTRY":"KWT","COUNTRY_NAME":"Kuwait"},{"COUNTRY":"OMN","COUNTRY_NAME":"Oman"},{"COUNTRY":"TON","COUNTRY_NAME":"Tonga"},{"COUNTRY":"SAU","COUNTRY_NAME":"Saudi Arabia"},{"COUNTRY":"DEU","COUNTRY_NAME":"Germany"},{"COUNTRY":"GBR","COUNTRY_NAME":"United Kingdom of Great Britain and Northern Ireland"},{"COUNTRY":"MDV","COUNTRY_NAME":"Maldives"},{"COUNTRY":"NIU","COUNTRY_NAME":"Niue"},{"COUNTRY":"BEN","COUNTRY_NAME":"Benin"},{"COUNTRY":"SLB","COUNTRY_NAME":"Solomon Islands"},{"COUNTRY":"MKD","COUNTRY_NAME":"North Macedonia"},{"COUNTRY":"LBR","COUNTRY_NAME":"Liberia"},{"COUNTRY":"CYP","COUNTRY_NAME":"Cyprus"},{"COUNTRY":"ARE","COUNTRY_NAME":"United Arab Emirates"}]},"ig11DataSrc":{"dataSource":"WUENIC, VIMC, Étude mondiale sur la charge de morbidité et autres données de modèles tirées de la littérature publiée"},"ig12DataSrc":{"dataSource":"Rapports de comités sur la vérification, la certification spécifiques à une maladie."},"ig13DataSrc":{"dataSource":"Programmes de lutte contre les MEV et systèmes de surveillance des urgences sanitaires mondiales de l'OMS"},"ig21DataSrc":{"dataSource":"WUENIC et PNUD"},"ig22DataSrc":{"dataSource":"JRF"},"ig31DataSrc":{"dataSource":"WUENIC, Estimations OMS/UNICEF de la couverture du VPH"},"ig32DataSrc":{"dataSource":"Indice de couverture sanitaire universelle"},"sp12DataSrc":{"dataSource":"OMS NHWA et UNPD WPP"},"sp16DataSrc":{"dataSource":"JRF"},"sp21DataSrc":{"dataSource":"JRF"},"sp22DataSrc":{"dataSource":"JRF"},"sp32DataSrc":{"dataSource":"Couverture administrative signalée dans le JRF"},"sp41DataSrc":{"dataSource":"WUENIC, Estimations OMS/UNICEF de la couverture du VPH"},"sp51DataSrc":{"dataSource":"Programmes nationaux de vaccination et de surveillance des maladies GIC, IRM, IMEP, OMS"},"sp61DataSrc":{"dataSource":"UNICEF, OMS, Secrétariat de Gavi et BMGF"},"sp62DataSrc":{"dataSource":"OMS GHED"},"sp63DataSrc":{"dataSource":"JRF"},"sp71DataSrc":{"dataSource":"JRF"},"ig11Region":{"nodes":[{"IA2030_IND":"IG1.1","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2023,"INDCODE":"ESTIMATED_DEATHS_AVERTED","VALUE_NUM":189339.027923,"DIMENSION2":null},{"IA2030_IND":"IG1.1","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2021,"INDCODE":"ESTIMATED_DEATHS_AVERTED","VALUE_NUM":197870.607883,"DIMENSION2":null},{"IA2030_IND":"IG1.1","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2024,"INDCODE":"ESTIMATED_DEATHS_AVERTED","VALUE_NUM":186636.719125,"DIMENSION2":null},{"IA2030_IND":"IG1.1","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2019,"INDCODE":"ESTIMATED_DEATHS_AVERTED","VALUE_NUM":209640.257956,"DIMENSION2":null},{"IA2030_IND":"IG1.1","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2022,"INDCODE":"ESTIMATED_DEATHS_AVERTED","VALUE_NUM":196748.502877,"DIMENSION2":null}]},"ig12Region":{"nodes":[{"IA2030_IND":"IG1.2","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2020,"INDCODE":"VPD_TARGET_MEASLES","DIMENSION2":"Re-established","VALUE_NUM":11.320755,"NUMERATOR":6,"DENOMINATOR":53},{"IA2030_IND":"IG1.2","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2021,"INDCODE":"VPD_TARGET_MEASLES","DIMENSION2":"Achieved","VALUE_NUM":62.264151,"NUMERATOR":33,"DENOMINATOR":53},{"IA2030_IND":"IG1.2","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2021,"INDCODE":"VPD_TARGET_POLIO_WILD","DIMENSION2":"Achieved","VALUE_NUM":100,"NUMERATOR":53,"DENOMINATOR":53},{"IA2030_IND":"IG1.2","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2022,"INDCODE":"VPD_TARGET_RUBELLA","DIMENSION2":"Not Achieved","VALUE_NUM":5.660377,"NUMERATOR":3,"DENOMINATOR":53},{"IA2030_IND":"IG1.2","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2024,"INDCODE":"VPD_TARGET_MEASLES","DIMENSION2":"Not Achieved","VALUE_NUM":35.849057,"NUMERATOR":19,"DENOMINATOR":53},{"IA2030_IND":"IG1.2","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2024,"INDCODE":"VPD_TARGET_POLIO_WILD","DIMENSION2":"Achieved","VALUE_NUM":100,"NUMERATOR":53,"DENOMINATOR":53},{"IA2030_IND":"IG1.2","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2024,"INDCODE":"VPD_TARGET_RUBELLA","DIMENSION2":"Achieved","VALUE_NUM":94.339623,"NUMERATOR":50,"DENOMINATOR":53},{"IA2030_IND":"IG1.2","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2020,"INDCODE":"VPD_TARGET_NTETANUS","DIMENSION2":"Achieved","VALUE_NUM":100,"NUMERATOR":53,"DENOMINATOR":53},{"IA2030_IND":"IG1.2","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2021,"INDCODE":"VPD_TARGET_MEASLES","DIMENSION2":"Not Achieved","VALUE_NUM":26.415094,"NUMERATOR":14,"DENOMINATOR":53},{"IA2030_IND":"IG1.2","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2022,"INDCODE":"VPD_TARGET_MEASLES","DIMENSION2":"Re-established","VALUE_NUM":9.433962,"NUMERATOR":5,"DENOMINATOR":53},{"IA2030_IND":"IG1.2","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2023,"INDCODE":"VPD_TARGET_MEASLES","DIMENSION2":"Not Achieved","VALUE_NUM":32.075472,"NUMERATOR":17,"DENOMINATOR":53},{"IA2030_IND":"IG1.2","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2023,"INDCODE":"VPD_TARGET_RUBELLA","DIMENSION2":"Achieved","VALUE_NUM":94.339623,"NUMERATOR":50,"DENOMINATOR":53},{"IA2030_IND":"IG1.2","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2024,"INDCODE":"VPD_TARGET_RUBELLA","DIMENSION2":"Not Achieved","VALUE_NUM":5.660377,"NUMERATOR":3,"DENOMINATOR":53},{"IA2030_IND":"IG1.2","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2023,"INDCODE":"VPD_TARGET_RUBELLA","DIMENSION2":"Not Achieved","VALUE_NUM":5.660377,"NUMERATOR":3,"DENOMINATOR":53},{"IA2030_IND":"IG1.2","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2020,"INDCODE":"VPD_TARGET_MEASLES","DIMENSION2":"Not Achieved","VALUE_NUM":26.415094,"NUMERATOR":14,"DENOMINATOR":53},{"IA2030_IND":"IG1.2","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2020,"INDCODE":"VPD_TARGET_RUBELLA","DIMENSION2":"Not Achieved","VALUE_NUM":7.54717,"NUMERATOR":4,"DENOMINATOR":53},{"IA2030_IND":"IG1.2","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2020,"INDCODE":"VPD_TARGET_RUBELLA","DIMENSION2":"Achieved","VALUE_NUM":92.45283,"NUMERATOR":49,"DENOMINATOR":53},{"IA2030_IND":"IG1.2","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2022,"INDCODE":"VPD_TARGET_MEASLES","DIMENSION2":"Achieved","VALUE_NUM":66.037736,"NUMERATOR":35,"DENOMINATOR":53},{"IA2030_IND":"IG1.2","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2022,"INDCODE":"VPD_TARGET_NTETANUS","DIMENSION2":"Achieved","VALUE_NUM":100,"NUMERATOR":53,"DENOMINATOR":53},{"IA2030_IND":"IG1.2","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2023,"INDCODE":"VPD_TARGET_MEASLES","DIMENSION2":"Re-established","VALUE_NUM":3.773585,"NUMERATOR":2,"DENOMINATOR":53},{"IA2030_IND":"IG1.2","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2024,"INDCODE":"VPD_TARGET_MEASLES","DIMENSION2":"Achieved","VALUE_NUM":64.150943,"NUMERATOR":34,"DENOMINATOR":53},{"IA2030_IND":"IG1.2","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2021,"INDCODE":"VPD_TARGET_NTETANUS","DIMENSION2":"Achieved","VALUE_NUM":100,"NUMERATOR":53,"DENOMINATOR":53},{"IA2030_IND":"IG1.2","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2023,"INDCODE":"VPD_TARGET_MEASLES","DIMENSION2":"Achieved","VALUE_NUM":64.150943,"NUMERATOR":34,"DENOMINATOR":53},{"IA2030_IND":"IG1.2","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2024,"INDCODE":"VPD_TARGET_NTETANUS","DIMENSION2":"Achieved","VALUE_NUM":100,"NUMERATOR":53,"DENOMINATOR":53},{"IA2030_IND":"IG1.2","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2021,"INDCODE":"VPD_TARGET_MEASLES","DIMENSION2":"Re-established","VALUE_NUM":11.320755,"NUMERATOR":6,"DENOMINATOR":53},{"IA2030_IND":"IG1.2","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2022,"INDCODE":"VPD_TARGET_RUBELLA","DIMENSION2":"Achieved","VALUE_NUM":94.339623,"NUMERATOR":50,"DENOMINATOR":53},{"IA2030_IND":"IG1.2","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2020,"INDCODE":"VPD_TARGET_MEASLES","DIMENSION2":"Achieved","VALUE_NUM":62.264151,"NUMERATOR":33,"DENOMINATOR":53},{"IA2030_IND":"IG1.2","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2020,"INDCODE":"VPD_TARGET_POLIO_WILD","DIMENSION2":"Achieved","VALUE_NUM":100,"NUMERATOR":53,"DENOMINATOR":53},{"IA2030_IND":"IG1.2","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2021,"INDCODE":"VPD_TARGET_RUBELLA","DIMENSION2":"Achieved","VALUE_NUM":92.45283,"NUMERATOR":49,"DENOMINATOR":53},{"IA2030_IND":"IG1.2","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2023,"INDCODE":"VPD_TARGET_NTETANUS","DIMENSION2":"Achieved","VALUE_NUM":100,"NUMERATOR":53,"DENOMINATOR":53},{"IA2030_IND":"IG1.2","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2023,"INDCODE":"VPD_TARGET_POLIO_WILD","DIMENSION2":"Achieved","VALUE_NUM":100,"NUMERATOR":53,"DENOMINATOR":53},{"IA2030_IND":"IG1.2","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2021,"INDCODE":"VPD_TARGET_RUBELLA","DIMENSION2":"Not Achieved","VALUE_NUM":7.54717,"NUMERATOR":4,"DENOMINATOR":53},{"IA2030_IND":"IG1.2","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2022,"INDCODE":"VPD_TARGET_MEASLES","DIMENSION2":"Not Achieved","VALUE_NUM":24.528302,"NUMERATOR":13,"DENOMINATOR":53},{"IA2030_IND":"IG1.2","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2022,"INDCODE":"VPD_TARGET_POLIO_WILD","DIMENSION2":"Achieved","VALUE_NUM":100,"NUMERATOR":53,"DENOMINATOR":53}]},"ig13Region":{"nodes":[{"IA2030_IND":"IG1.3","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":null,"YEAR_RANGE":"2018-2020","INDCODE":"LARGE_DISRUPTIVE_VPD_OUTBREAK","DIMENSION2":null,"VALUE_NUM":11},{"IA2030_IND":"IG1.3","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2021,"YEAR_RANGE":null,"INDCODE":"LARGE_DISRUPTIVE_VPD_OUTBREAK","DIMENSION2":null,"VALUE_NUM":3},{"IA2030_IND":"IG1.3","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2022,"YEAR_RANGE":null,"INDCODE":"LARGE_DISRUPTIVE_VPD_OUTBREAK","DIMENSION2":null,"VALUE_NUM":3},{"IA2030_IND":"IG1.3","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2023,"YEAR_RANGE":null,"INDCODE":"LARGE_DISRUPTIVE_VPD_OUTBREAK","DIMENSION2":null,"VALUE_NUM":11},{"IA2030_IND":"IG1.3","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2024,"YEAR_RANGE":null,"INDCODE":"LARGE_DISRUPTIVE_VPD_OUTBREAK","DIMENSION2":null,"VALUE_NUM":24}]},"ig21Region":{"nodes":[{"IA2030_IND":"IG2.1","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2023,"INDCODE":"ZERO_DOSE","VALUE_NUM":365731},{"IA2030_IND":"IG2.1","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2022,"INDCODE":"ZERO_DOSE","VALUE_NUM":386114},{"IA2030_IND":"IG2.1","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2019,"INDCODE":"ZERO_DOSE","VALUE_NUM":353401},{"IA2030_IND":"IG2.1","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2021,"INDCODE":"ZERO_DOSE","VALUE_NUM":414312},{"IA2030_IND":"IG2.1","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2024,"INDCODE":"ZERO_DOSE","VALUE_NUM":439888}]},"ig22Region":{"nodes":[{"IA2030_IND":"IG2.2","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2022,"INDCODE":"VACCINE_INTRO","VALUE_NUM":11,"DIMENSION2":null},{"IA2030_IND":"IG2.2","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2021,"INDCODE":"VACCINE_INTRO","VALUE_NUM":18,"DIMENSION2":null},{"IA2030_IND":"IG2.2","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2023,"INDCODE":"VACCINE_INTRO","VALUE_NUM":1,"DIMENSION2":null},{"IA2030_IND":"IG2.2","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2024,"INDCODE":"VACCINE_INTRO","VALUE_NUM":2,"DIMENSION2":null}]},"ig31Region":{"nodes":[{"IA2030_IND":"IG3.1","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2019,"INDCODE":"LIFE_COURSE_COVERAGE","DIMENSION2":"DTPCV3","VALUE_NUM":94.8377},{"IA2030_IND":"IG3.1","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2019,"INDCODE":"LIFE_COURSE_COVERAGE","DIMENSION2":"PRHPVC_F","VALUE_NUM":28.0667},{"IA2030_IND":"IG3.1","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2022,"INDCODE":"LIFE_COURSE_COVERAGE","DIMENSION2":"PRHPVC_F","VALUE_NUM":33.9268},{"IA2030_IND":"IG3.1","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2023,"INDCODE":"LIFE_COURSE_COVERAGE","DIMENSION2":"PRHPVC_F","VALUE_NUM":36.0252},{"IA2030_IND":"IG3.1","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2019,"INDCODE":"LIFE_COURSE_COVERAGE","DIMENSION2":"MCV2","VALUE_NUM":92.1495},{"IA2030_IND":"IG3.1","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2022,"INDCODE":"LIFE_COURSE_COVERAGE","DIMENSION2":"PCV3","VALUE_NUM":83.6528},{"IA2030_IND":"IG3.1","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2021,"INDCODE":"LIFE_COURSE_COVERAGE","DIMENSION2":"PRHPVC_F","VALUE_NUM":31.4848},{"IA2030_IND":"IG3.1","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2023,"INDCODE":"LIFE_COURSE_COVERAGE","DIMENSION2":"DTPCV3","VALUE_NUM":94.2037},{"IA2030_IND":"IG3.1","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2021,"INDCODE":"LIFE_COURSE_COVERAGE","DIMENSION2":"MCV2","VALUE_NUM":91.8029},{"IA2030_IND":"IG3.1","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2022,"INDCODE":"LIFE_COURSE_COVERAGE","DIMENSION2":"MCV2","VALUE_NUM":91.4271},{"IA2030_IND":"IG3.1","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2023,"INDCODE":"LIFE_COURSE_COVERAGE","DIMENSION2":"MCV2","VALUE_NUM":90.9466},{"IA2030_IND":"IG3.1","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2021,"INDCODE":"LIFE_COURSE_COVERAGE","DIMENSION2":"PCV3","VALUE_NUM":83.034},{"IA2030_IND":"IG3.1","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2021,"INDCODE":"LIFE_COURSE_COVERAGE","DIMENSION2":"DTPCV3","VALUE_NUM":93.7438},{"IA2030_IND":"IG3.1","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2024,"INDCODE":"LIFE_COURSE_COVERAGE","DIMENSION2":"DTPCV3","VALUE_NUM":93.3444},{"IA2030_IND":"IG3.1","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2024,"INDCODE":"LIFE_COURSE_COVERAGE","DIMENSION2":"PCV3","VALUE_NUM":85.8801},{"IA2030_IND":"IG3.1","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2024,"INDCODE":"LIFE_COURSE_COVERAGE","DIMENSION2":"MCV2","VALUE_NUM":90.52},{"IA2030_IND":"IG3.1","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2024,"INDCODE":"LIFE_COURSE_COVERAGE","DIMENSION2":"PRHPVC_F","VALUE_NUM":37.6007},{"IA2030_IND":"IG3.1","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2022,"INDCODE":"LIFE_COURSE_COVERAGE","DIMENSION2":"DTPCV3","VALUE_NUM":94.2229},{"IA2030_IND":"IG3.1","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2019,"INDCODE":"LIFE_COURSE_COVERAGE","DIMENSION2":"PCV3","VALUE_NUM":80.7049},{"IA2030_IND":"IG3.1","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2023,"INDCODE":"LIFE_COURSE_COVERAGE","DIMENSION2":"PCV3","VALUE_NUM":84.7457}]},"ig32Region":{"nodes":[{"IA2030_IND":"IG3.2","CATEGORY":"WHO_REGIONS","CODE":"EURO","INDCODE":"UHC_SCI","VALUE_NUM":81.064707,"YEAR":2021},{"IA2030_IND":"IG3.2","CATEGORY":"WHO_REGIONS","CODE":"EURO","INDCODE":"UHC_SCI","VALUE_NUM":81.31508,"YEAR":2019}]},"sp12Region":{"nodes":[{"IA2030_IND":"SP1.2","CATEGORY":"WHO_REGIONS","CODE":"EURO","INDCODE":"HEALTH_WORKFORCE_DENSITY","VALUE_NUM":120.37,"YEAR":2021},{"IA2030_IND":"SP1.2","CATEGORY":"WHO_REGIONS","CODE":"EURO","INDCODE":"HEALTH_WORKFORCE_DENSITY","VALUE_NUM":118.83,"YEAR":2022},{"IA2030_IND":"SP1.2","CATEGORY":"WHO_REGIONS","CODE":"EURO","INDCODE":"HEALTH_WORKFORCE_DENSITY","VALUE_NUM":119.9,"YEAR":2023},{"IA2030_IND":"SP1.2","CATEGORY":"WHO_REGIONS","CODE":"EURO","INDCODE":"HEALTH_WORKFORCE_DENSITY","VALUE_NUM":119.52,"YEAR":2020}]},"sp16Region":{"nodes":[{"IA2030_IND":"SP1.6","CATEGORY":"WHO_REGIONS","CODE":"EURO","INDCODE":"VIGIBASE_SERIOUS_AEFI","VALUE_NUM":71.698113,"YEAR":2023,"NUMERATOR":38,"DENOMINATOR":53},{"IA2030_IND":"SP1.6","CATEGORY":"WHO_REGIONS","CODE":"EURO","INDCODE":"VIGIBASE_SERIOUS_AEFI","VALUE_NUM":75.471698,"YEAR":2024,"NUMERATOR":40,"DENOMINATOR":53},{"IA2030_IND":"SP1.6","CATEGORY":"WHO_REGIONS","CODE":"EURO","INDCODE":"VIGIBASE_SERIOUS_AEFI","VALUE_NUM":77.358491,"YEAR":2022,"NUMERATOR":41,"DENOMINATOR":53},{"IA2030_IND":"SP1.6","CATEGORY":"WHO_REGIONS","CODE":"EURO","INDCODE":"VIGIBASE_SERIOUS_AEFI","VALUE_NUM":81.132075,"YEAR":2021,"NUMERATOR":43,"DENOMINATOR":53}]},"sp21Region":{"nodes":[{"IA2030_IND":"SP2.1","CATEGORY":"WHO_REGIONS","CODE":"EURO","INDCODE":"VAC_LAW","DIMENSION2":"ND_NR_NORESPONSE","NUMERATOR":1,"DENOMINATOR":53,"VALUE_NUM":1.886792,"YEAR":2023},{"IA2030_IND":"SP2.1","CATEGORY":"WHO_REGIONS","CODE":"EURO","INDCODE":"VAC_LAW","DIMENSION2":"NO","NUMERATOR":6,"DENOMINATOR":53,"VALUE_NUM":11.320755,"YEAR":2023},{"IA2030_IND":"SP2.1","CATEGORY":"WHO_REGIONS","CODE":"EURO","INDCODE":"VAC_LAW","DIMENSION2":"NO","NUMERATOR":7,"DENOMINATOR":53,"VALUE_NUM":13.207547,"YEAR":2021},{"IA2030_IND":"SP2.1","CATEGORY":"WHO_REGIONS","CODE":"EURO","INDCODE":"VAC_LAW","DIMENSION2":"NO","NUMERATOR":8,"DENOMINATOR":53,"VALUE_NUM":15.09434,"YEAR":2022},{"IA2030_IND":"SP2.1","CATEGORY":"WHO_REGIONS","CODE":"EURO","INDCODE":"VAC_LAW","DIMENSION2":"YES","NUMERATOR":44,"DENOMINATOR":53,"VALUE_NUM":83.018868,"YEAR":2022},{"IA2030_IND":"SP2.1","CATEGORY":"WHO_REGIONS","CODE":"EURO","INDCODE":"VAC_LAW","DIMENSION2":"NO","NUMERATOR":7,"DENOMINATOR":53,"VALUE_NUM":13.207547,"YEAR":2024},{"IA2030_IND":"SP2.1","CATEGORY":"WHO_REGIONS","CODE":"EURO","INDCODE":"VAC_LAW","DIMENSION2":"YES","NUMERATOR":43,"DENOMINATOR":53,"VALUE_NUM":81.132075,"YEAR":2024},{"IA2030_IND":"SP2.1","CATEGORY":"WHO_REGIONS","CODE":"EURO","INDCODE":"VAC_LAW","DIMENSION2":"ND_NR_NORESPONSE","NUMERATOR":1,"DENOMINATOR":53,"VALUE_NUM":1.886792,"YEAR":2022},{"IA2030_IND":"SP2.1","CATEGORY":"WHO_REGIONS","CODE":"EURO","INDCODE":"VAC_LAW","DIMENSION2":"ND_NR_NORESPONSE","NUMERATOR":1,"DENOMINATOR":53,"VALUE_NUM":1.886792,"YEAR":2021},{"IA2030_IND":"SP2.1","CATEGORY":"WHO_REGIONS","CODE":"EURO","INDCODE":"VAC_LAW","DIMENSION2":"YES","NUMERATOR":46,"DENOMINATOR":53,"VALUE_NUM":86.792453,"YEAR":2023},{"IA2030_IND":"SP2.1","CATEGORY":"WHO_REGIONS","CODE":"EURO","INDCODE":"VAC_LAW","DIMENSION2":"ND_NR_NORESPONSE","NUMERATOR":3,"DENOMINATOR":53,"VALUE_NUM":5.660377,"YEAR":2024},{"IA2030_IND":"SP2.1","CATEGORY":"WHO_REGIONS","CODE":"EURO","INDCODE":"VAC_LAW","DIMENSION2":"YES","NUMERATOR":45,"DENOMINATOR":53,"VALUE_NUM":84.90566,"YEAR":2021}]},"sp22Region":{"nodes":[{"IA2030_IND":"SP2.2","CATEGORY":"WHO_REGIONS","CODE":"EURO","INDCODE":"DEMAND_STRATEGIES","DIMENSION2":"ND_NR_NORESPONSE","NUMERATOR":9,"DENOMINATOR":53,"VALUE_NUM":16.981132,"YEAR":2023},{"IA2030_IND":"SP2.2","CATEGORY":"WHO_REGIONS","CODE":"EURO","INDCODE":"DEMAND_STRATEGIES","DIMENSION2":"NO","NUMERATOR":15,"DENOMINATOR":53,"VALUE_NUM":28.301887,"YEAR":2024},{"IA2030_IND":"SP2.2","CATEGORY":"WHO_REGIONS","CODE":"EURO","INDCODE":"DEMAND_STRATEGIES","DIMENSION2":"YES","NUMERATOR":30,"DENOMINATOR":53,"VALUE_NUM":56.603774,"YEAR":2023},{"IA2030_IND":"SP2.2","CATEGORY":"WHO_REGIONS","CODE":"EURO","INDCODE":"DEMAND_STRATEGIES","DIMENSION2":"YES","NUMERATOR":35,"DENOMINATOR":53,"VALUE_NUM":66.037736,"YEAR":2021},{"IA2030_IND":"SP2.2","CATEGORY":"WHO_REGIONS","CODE":"EURO","INDCODE":"DEMAND_STRATEGIES","DIMENSION2":"YES","NUMERATOR":16,"DENOMINATOR":53,"VALUE_NUM":30.188679,"YEAR":2022},{"IA2030_IND":"SP2.2","CATEGORY":"WHO_REGIONS","CODE":"EURO","INDCODE":"DEMAND_STRATEGIES","DIMENSION2":"YES","NUMERATOR":28,"DENOMINATOR":53,"VALUE_NUM":52.830189,"YEAR":2024},{"IA2030_IND":"SP2.2","CATEGORY":"WHO_REGIONS","CODE":"EURO","INDCODE":"DEMAND_STRATEGIES","DIMENSION2":"ND_NR_NORESPONSE","NUMERATOR":2,"DENOMINATOR":53,"VALUE_NUM":3.773585,"YEAR":2021},{"IA2030_IND":"SP2.2","CATEGORY":"WHO_REGIONS","CODE":"EURO","INDCODE":"DEMAND_STRATEGIES","DIMENSION2":"ND_NR_NORESPONSE","NUMERATOR":13,"DENOMINATOR":53,"VALUE_NUM":24.528302,"YEAR":2022},{"IA2030_IND":"SP2.2","CATEGORY":"WHO_REGIONS","CODE":"EURO","INDCODE":"DEMAND_STRATEGIES","DIMENSION2":"NO","NUMERATOR":24,"DENOMINATOR":53,"VALUE_NUM":45.283019,"YEAR":2022},{"IA2030_IND":"SP2.2","CATEGORY":"WHO_REGIONS","CODE":"EURO","INDCODE":"DEMAND_STRATEGIES","DIMENSION2":"ND_NR_NORESPONSE","NUMERATOR":10,"DENOMINATOR":53,"VALUE_NUM":18.867925,"YEAR":2024},{"IA2030_IND":"SP2.2","CATEGORY":"WHO_REGIONS","CODE":"EURO","INDCODE":"DEMAND_STRATEGIES","DIMENSION2":"NO","NUMERATOR":16,"DENOMINATOR":53,"VALUE_NUM":30.188679,"YEAR":2021},{"IA2030_IND":"SP2.2","CATEGORY":"WHO_REGIONS","CODE":"EURO","INDCODE":"DEMAND_STRATEGIES","DIMENSION2":"NO","NUMERATOR":14,"DENOMINATOR":53,"VALUE_NUM":26.415094,"YEAR":2023}]},"sp32Region":{"nodes":[{"IA2030_IND":"SP3.2","CATEGORY":"WHO_REGIONS","CODE":"EURO","INDCODE":"DISTRICT_COVERAGE_LOW20","DIMENSION2":"MCV2","VALUE_NUM":87.197607,"YEAR":2019},{"IA2030_IND":"SP3.2","CATEGORY":"WHO_REGIONS","CODE":"EURO","INDCODE":"DISTRICT_COVERAGE_LOW20","DIMENSION2":"MCV2","VALUE_NUM":80.359261,"YEAR":2021},{"IA2030_IND":"SP3.2","CATEGORY":"WHO_REGIONS","CODE":"EURO","INDCODE":"DISTRICT_COVERAGE_LOW20","DIMENSION2":"MCV1","VALUE_NUM":75.263128,"YEAR":2022},{"IA2030_IND":"SP3.2","CATEGORY":"WHO_REGIONS","CODE":"EURO","INDCODE":"DISTRICT_COVERAGE_LOW20","DIMENSION2":"MCV1","VALUE_NUM":78.654042,"YEAR":2023},{"IA2030_IND":"SP3.2","CATEGORY":"WHO_REGIONS","CODE":"EURO","INDCODE":"DISTRICT_COVERAGE_LOW20","DIMENSION2":"MCV1","VALUE_NUM":77.537407,"YEAR":2021},{"IA2030_IND":"SP3.2","CATEGORY":"WHO_REGIONS","CODE":"EURO","INDCODE":"DISTRICT_COVERAGE_LOW20","DIMENSION2":"DTPCV3","VALUE_NUM":81.315273,"YEAR":2022},{"IA2030_IND":"SP3.2","CATEGORY":"WHO_REGIONS","CODE":"EURO","INDCODE":"DISTRICT_COVERAGE_LOW20","DIMENSION2":"MCV2","VALUE_NUM":80.887715,"YEAR":2024},{"IA2030_IND":"SP3.2","CATEGORY":"WHO_REGIONS","CODE":"EURO","INDCODE":"DISTRICT_COVERAGE_LOW20","DIMENSION2":"DTPCV3","VALUE_NUM":79.412966,"YEAR":2023},{"IA2030_IND":"SP3.2","CATEGORY":"WHO_REGIONS","CODE":"EURO","INDCODE":"DISTRICT_COVERAGE_LOW20","DIMENSION2":"DTPCV3","VALUE_NUM":80.871133,"YEAR":2024},{"IA2030_IND":"SP3.2","CATEGORY":"WHO_REGIONS","CODE":"EURO","INDCODE":"DISTRICT_COVERAGE_LOW20","DIMENSION2":"DTPCV3","VALUE_NUM":86.308313,"YEAR":2019},{"IA2030_IND":"SP3.2","CATEGORY":"WHO_REGIONS","CODE":"EURO","INDCODE":"DISTRICT_COVERAGE_LOW20","DIMENSION2":"DTPCV3","VALUE_NUM":81.435526,"YEAR":2021},{"IA2030_IND":"SP3.2","CATEGORY":"WHO_REGIONS","CODE":"EURO","INDCODE":"DISTRICT_COVERAGE_LOW20","DIMENSION2":"MCV1","VALUE_NUM":83.959414,"YEAR":2019},{"IA2030_IND":"SP3.2","CATEGORY":"WHO_REGIONS","CODE":"EURO","INDCODE":"DISTRICT_COVERAGE_LOW20","DIMENSION2":"MCV2","VALUE_NUM":81.486176,"YEAR":2023},{"IA2030_IND":"SP3.2","CATEGORY":"WHO_REGIONS","CODE":"EURO","INDCODE":"DISTRICT_COVERAGE_LOW20","DIMENSION2":"MCV2","VALUE_NUM":75.659684,"YEAR":2022},{"IA2030_IND":"SP3.2","CATEGORY":"WHO_REGIONS","CODE":"EURO","INDCODE":"DISTRICT_COVERAGE_LOW20","DIMENSION2":"MCV1","VALUE_NUM":76.201664,"YEAR":2024}]},"sp41Region":{"nodes":[{"IA2030_IND":"SP4.1","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2019,"INDCODE":"BREADTH_OF_PROTECTION","DIMENSION2":null,"VALUE_NUM":79.470081},{"IA2030_IND":"SP4.1","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2021,"INDCODE":"BREADTH_OF_PROTECTION","DIMENSION2":null,"VALUE_NUM":80.188209},{"IA2030_IND":"SP4.1","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2023,"INDCODE":"BREADTH_OF_PROTECTION","DIMENSION2":null,"VALUE_NUM":82.773109},{"IA2030_IND":"SP4.1","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2024,"INDCODE":"BREADTH_OF_PROTECTION","DIMENSION2":null,"VALUE_NUM":82.727},{"IA2030_IND":"SP4.1","CATEGORY":"WHO_REGIONS","CODE":"EURO","YEAR":2022,"INDCODE":"BREADTH_OF_PROTECTION","DIMENSION2":null,"VALUE_NUM":81.922581}]},"sp71Region":{"nodes":[]}},"pageContext":{"iSO3":"UZB","countryName":"Uzbekistan","region":"EUR","wisemartRegion":"EURO","incomeGroup":"WBLMIC","unicefRegion":"ECAR","language":"fr","i18n":{"language":"fr","languages":["en","fr"],"defaultLanguage":"en","generateDefaultLanguagePage":false,"routed":true,"originalPath":"/country/uzb","path":"fr/country/uzb"}}},
    "staticQueryHashes": ["1369425039","1445333947","1552799858","1612644333","174287916","2018359174","2371382783","3075409314","315369492","347271350","4121627061","4189822119","4219143213"]}